Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Sleep|December 1, 1993
Desmethyl metabolites of serotonergic uptake inhibitors are more potent for suppressing canine cataplexy than their parent compoundsS Nishino, J Arrigoni, J Shelton, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1993
Further characterization of the alpha-1 receptor subtype involved in the control of cataplexy in canine narcolepsyS Nishino, B Fruhstorfer, J Arrigoni, et al.
Psychopharmacology|January 1, 1993
Canine cataplexy is preferentially controlled by adrenergic mechanisms: evidence using monoamine selective uptake inhibitors and release enhancersE Mignot, A Renaud, S Nishino, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|August 15, 1997
Effects of thyrotropin-releasing hormone and its analogs on daytime sleepiness and cataplexy in canine narcolepsyS Nishino, J Arrigoni, J Shelton, et al.
Sleep|February 16, 1999
Validation of a cataplexy questionnaire in 983 sleep-disorders patientsS Anic-Labat, C Guilleminault, H C Kraemer, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 1, 1991
Dopamine D2 mechanisms in canine narcolepsyS Nishino, J Arrigoni, D Valtier, et al.
Sleep|October 1, 1992
DQB1-0602 (DQw1) is not present in most nonDR2 Caucasian narcolepticsE Mignot, X Lin, J Kalil, et al.
Sleep|December 1, 1994
DQB1*0602 and DQA1*0102 (DQ1) are better markers than DR2 for narcolepsy in Caucasian and black AmericansE Mignot, X Lin, J Arrigoni, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 1, 1993
Heterozygosity at the canarc-1 locus can confer susceptibility for narcolepsy: induction of cataplexy in heterozygous asymptomatic dogs after administration of a combination of drugs acting on monoaminergic and cholinergic systemsE Mignot, S Nishino, L H Sharp, et al.
Pageof 1